DarioHealth Revenue Rises 6% in Third Quarter

The digital health company narrowed its net loss while operating expenses fell 10% year over year.

Updated on Nov. 12, 2026 in Healthcare

Bold flat-color editorial illustration of three solid navy and cream blocks of varying height beside a single small red block, conveying measured financial progress.
DarioHealth Corp. reported third-quarter revenue of $5.311 million, up 6.1% from a year earlier, while cutting operating expenses 10% and narrowing its net loss to $8.849 million. AI Illustration. Upload story photo >

DarioHealth Corp. reported third-quarter 2026 revenue of $5.311 million, up 6.1% from $5.007 million a year earlier. The company's net loss narrowed to $8.849 million from $10.466 million for the period ended Sept. 30, 2026.

Why it matters

The results show revenue growth alongside reduced spending, a combination that can extend the runway for a company still operating at a loss. Cash and short-term deposits of $31.2 million at quarter-end provide the financial backing for that effort.

Operating loss narrowed to $8 million from $9.5 million a year earlier, a 15% reduction, with basic and diluted loss per share of $0.73. The report does not provide guidance on whether the operating loss reduction will persist.

The players

DarioHealth Corp.

DarioHealth is a publicly traded digital health company that provides chronic condition management and remote care services.

The details

DarioHealth Corp. grew revenue while cutting operating expenses by 10% to $11.2 million, reducing its operating loss by 15% year over year. The company ended the quarter with $31.2 million in cash, cash equivalents and short-term deposits.

Timeline

  1. Sept. 30, 2025: Prior-year quarter comparison period ends.

  2. Sept. 30, 2026: Third-quarter 2026 period ends and results are reported.

Market Landscape

Public digital health companies have faced pressure to reduce losses while growing revenue, and DarioHealth's combination of a 6.1% revenue gain and a 10% expense cut reflects that pressure. The filing does not place the company's results against specific competitors or sector benchmarks.

For investors and patients using DarioHealth's services, the narrowed loss and maintained cash balance indicate the company's near-term financial position. The filing does not indicate any change to pricing or product availability for customers.

The takeaway

Investors tracking digital health companies can use operating expense trends and cash balances alongside revenue growth to gauge progress toward profitability. Quarterly results show direction, but the filing alone does not establish whether the trend will hold.

Further reading

Explore more United States Healthcare news and business coverage.

Source note: This article includes information reported by TokenPost.